Delivery Order SPE2DB22D3301-SPE2DB25FY3BL
Award Date
4/10/25
Potential Completion Date
4/11/25
Potential Value
$1K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a firm fixed price, a ceiling value of $4,120.47, and a period of performance through May 16, 2025. The contract is not set aside and represents open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Candesartan Cilexetil 16 mg tablets. The contract has a ceiling value of $7,188.72 and an ultimate completion date of February 20, 2025. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The contract, valued at $7,897.46, is for the delivery of 4,567,137,152 units of Candesartan Cilexetil 16 mg tablets in 90-count bottles. The contract has an ultimate completion date of February 4, 2025 and utilizes a firm fixed-price pricing structure. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Candesartan Cilexetil 16 MG tablets in 90-count packages, with a ceiling value of $7,044.06 and a performance period through April 2025. The contract is not set aside and was awarded as a firm-fixed-price delivery order. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with DLA...
This is a federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,498.49, is for the delivery of 32 mg Candesartan Cilexetil tablets in 90-count bottles. The contract is a firm fixed-price delivery order with a completion date of March 13, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,625.23 firm fixed-price contract is for the supply of 90-count bottles of 16 mg Candesartan Cilexetil tablets, a cardiovascular medication. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation's Corporate Office division. The $14,410.55 firm fixed price contract is for the supply of Candesartan Cilexetil 16 MG tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and Amerisourcebergen, which provides a wide range of pharmaceutical and medical supplies to support military...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Candesartan Cilexetil 16 mg tablets, a prescription medication. The contract has a ceiling value of $39,839.69 and an ultimate completion date of September 6, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical,...
The Defense Logistics Agency (DLA) awarded a $1,245.51 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,566,830,917 units of Candesartan Cilexetil 32 mg tablets. This contract is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,875.50, is for the delivery of Candesartan Cilexetil 16 mg tablets. It is a firm fixed price delivery order contract that does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...